44792 Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices 

updated estimate (based on historical 

information) of state nonmember banks 

and state savings associations engaged 

in consumer leasing. In particular, the 

number of respondents has decreased 

while the hours per response remain the 

same. 

2. Title: Covered Financial Company 

Asset Purchaser Eligibility Certification. 

OMB Number: 3064–0194. 

Form Number: Covered Financial 

Company Asset Sales Purchaser 

Eligibility Certification—7300/10. 

Affected Public: Any individual or 

entity that is a potential purchaser of 

assets from (1) the FDIC as receiver for 

a Covered Financial Company (‘‘CFC’’); 

or (2) a bridge financial company 

(‘‘BFC’’) which requires the approval of 

the FDIC, as receiver for the predecessor 

CFC and as the sole shareholder of the 

BFC (e.g., the BFC’s sale of a significant 

business line). 

Burden Estimate: 

Type of burden 

Estimated 

number of 

respondents 

Estimated 

number of 

responses 

Estimated time 

per 

response 

(minutes) 

Frequency of 

response 

Total annual 

estimated 

burden 

(hours) 

Covered Financial Company 

Asset Sales Purchaser Eligibility Certification.

Reporting ............................. 10 1 30 Annual ......... 5 

Total Hourly Burden ...... .............................................. ........................ ........................ ........................ ..................... 5 

General Description of Collection: 

Assets held by the FDIC in the course 

of liquidating any covered financial 

company must not be sold to persons 

who contributed to the demise of a 

covered financial company in specified 

ways (e.g., individuals who profited or 

engaged in wrongdoing at the expense 

of the failed institution, or seriously 

mismanaged the failed institution). 12 

CFR part 380 requires prospective 

purchasers to complete and submit a 

Purchaser Eligibility Certification 

(‘‘PEC’’) to the FDIC. The PEC is a selfcertification by a prospective purchaser 

that it does not fall into any of the 

categories of individuals or entities that 

are prohibited by statute or regulation 

from purchasing the assets of covered 

financial companies. The PEC will be 

required in connection with the sale of 

assets by the FDIC, as receiver for a CFC, 

or the sale of assets by a BFC which 

requires the approval of the FDIC, as 

receiver for the predecessor CFC and as 

the sole shareholder of the BFC. 

There is no change in the method or 

substance of the collection. The number 

of respondents and the hours per 

response remain the same. 

Request for Comment 

Comments are invited on: (a) Whether 

the collections of information are 

necessary for the proper performance of 

the FDIC’s functions, including whether 

the information has practical utility; (b) 

the accuracy of the estimates of the 

burden of the information collections, 

including the validity of the 

methodology and assumptions used; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collections of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. All comments will become 

a matter of public record. 

Dated at Washington, DC, this 20th day of 

September 2017. 

Federal Deposit Insurance Corporation. 

Valerie J. Best, 

Assistant Executive Secretary. 

[FR Doc. 2017–20593 Filed 9–25–17; 8:45 am] 

BILLING CODE 6714–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–17–1080; Docket No. CDC 2017– 

0078] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing efforts to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies to take this opportunity to 

comment on proposed and/or 

continuing information collections, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on HIV Outpatient Study 

(HOPS). 

DATES: Written comments must be 

received on or before November 27, 

2017. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2017– 

0078 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Leroy A. Richardson, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE., MS– 

D74, Atlanta, Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. All relevant comments 

received will be posted without change 

to Regulations.gov, including any 

personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

Regulations.gov. 

Please note: All public comment should be 

submitted through the Federal eRulemaking 

portal (Regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Leroy A. 

Richardson, Information Collection 

Review Office, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road NE., MS–D74, Atlanta, Georgia 

30329; phone: 404–639–7570; Email: 

omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices 44793 

collection before submitting the 

collection to OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology; and (e) estimates of capital 

or start-up costs and costs of operation, 

maintenance, and purchase of services 

to provide information. Burden means 

the total time, effort, or financial 

resources expended by persons to 

generate, maintain, retain, disclose or 

provide information to or for a Federal 

agency. This includes the time needed 

to review instructions; to develop, 

acquire, install and utilize technology 

and systems for the purpose of 

collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information, to search 

data sources, to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. 

Proposed Project 

HIV Outpatient Study (HOPS) (OMB 

Control Number 0920–1080, Expiration, 

8/31/2018)—Revision—National Center 

for HIV/AIDS, Viral Hepatitis, STD, and 

TB Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The CDC requests a three-year 

approval and a revision to the HIV 

Outpatient Study data collection 

activity. The HIV Outpatient Study 

(HOPS) is a prospective longitudinal 

cohort of HIV-infected outpatients at 

eight well-established private HIV care 

practices and university-based U.S. 

clinics, in Tampa, Florida; Washington, 

DC; Stony Brook, New York; Chicago, 

Illinois; Denver, Colorado; and 

Philadelphia, Pennsylvania. Researchers 

abstract clinical data on an ongoing 

basis from the medical records of adult 

HIV-infected HOPS study participants, 

who also complete an optional 

telephone/Web-based behavioral 

assessment as part of their annual clinic 

visit, which on average takes about 

seven minutes. Before enrolling in this 

study, all potential study participants 

will undergo an informed consent 

process (including signing of a written 

informed consent), which is estimated 

to take 15 minutes. 

The revisions consist of adding 12 

additional survey questions to assess 

additional risk behaviors that may affect 

the long-term care and treatment of HIV 

positive patients participating in the 

HIV Outpatient Study. Based on review 

of the current survey response items and 

the average completion time, these new 

questions will not pose additional 

burden on participants. 

The core areas of HOPS research 

extending through the present HIV 

treatment era include: (i) Monitoring 

death rates and causes of death; (ii) 

characterizing the optimal patient 

management strategies to reduce HIV 

related morbidity and mortality (e.g., 

effectiveness of antiretroviral therapies 

and other clinical interventions); (iii) 

monitoring of sexual and drug use 

behaviors to inform Prevention with 

Positives; and (iv) investigating 

disparities in the HIV care continuum 

by various demographic factors. 

In recent years, the HOPS has been 

instrumental in bringing attention to 

emerging issues in chronic HIV 

infection with actionable opportunities 

for prevention, including cardiovascular 

disease, fragility fractures, renal and 

hepatic disease, and cancers. The HOPS 

remains an important source for multiyear trend data concerning conditions 

and behaviors for which data are not 

readily available elsewhere, to include: 

Rates of opportunistic illnesses, rates of 

comorbid conditions (e.g., hypertension, 

obesity, diabetes) and antiretroviral drug 

resistance. 

Researchers will collect data through 

medical record abstraction by trained 

abstractors and by telephone or Internet 

based, computer-assisted interviews at 

eight funded study sites in six U.S. 

cities. Collection of data abstracted from 

patient medical records provides data in 

five general categories: Demographics 

and risk behaviors for HIV infection; 

symptoms; diagnosed conditions 

(definitive and presumptive); 

medications prescribed (including dose, 

duration, and reasons for stopping); all 

laboratory values, including CD4+ 

Tlymphocyte (CD4+) cell counts, 

plasma HIV–RNA determinations, and 

genotype, phenotype, and trophile 

results. Researchers will acquire data on 

visit frequency, AIDS, and death from 

the clinic chart. Data collected using a 

brief Telephone Audio-Computer 

Assisted Self-Interview (T–ACASI) 

survey or an identical Web-based 

Audio-Computer Assisted SelfInterview (ACASI) include: Age, sex at 

birth, use of alcohol and drugs, cigarette 

smoking, adherence to antiretroviral 

medications, types of sexual 

intercourse, condom use, and disclosure 

of HIV status to partners. 

We anticipate the annual recruitment 

of 450 new HOPS study participants 

into the HOPS from a pool of HIVinfected individuals currently in HIVcare at nine clinics (50 patients per site). 

Researchers will approach patients 

during one of the patients’ routine clinic 

visits to participate in the HOPS. 

Researchers will give patients interested 

in participating in the HOPS detailed 

information about the nature of the 

study and provide them with a written 

informed consent form that the patient 

must complete prior to enrollment. 

Annually, the researchers will add the 

450 newly enrolled participants to the 

database of existing participants. 

Researchers will conduct medical 

record abstractions and will not impose 

direct burden on HOPS study 

participants. 

Participation of respondents is 

voluntary. There is no cost to the 

respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

hours 

HOPS study Patients ........................ Behavioral survey ............................. 2,500 1 7/60 292 

HOPS Study Patients ....................... Consent form .................................... 450 1 15/60 113 

Total ........................................... ........................................................... ........................ ........................ ........................ 405 

44794 Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2017–20511 Filed 9–25–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–17–17NW] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) has submitted the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on April 27, 

2017 to obtain comments from the 

public and affected agencies. CDC 

received one comment related to the 

previous notice. The purpose of this 

notice is to allow an additional 30 days 

for public comments. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. The Office 

of Management and Budget is 

particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Direct 

written comments and/or suggestions 

regarding the items contained in this 

notice to the Attention: CDC Desk 

Officer, Office of Management and 

Budget, 725 17th Street NW., 

Washington, DC 20503 or by fax to (202) 

395–5806. Provide written comments 

within 30 days of notice publication. 

Proposed Project 

A Novel Framework for Structuring 

Industry-Tuned Public-Private 

Partnerships and Economic Incentives 

for U.S. Health Emergency Preparedness 

and Response—New—Office of Public 

Health Preparedness and Response 

(OPHPR), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

Despite the important role of publicprivate partnerships in supporting the 

US’s public health preparedness and 

response mission, many partnership 

efforts are not successful due to poorly 

aligned incentives or lack of awareness 

of external market factors. There is little 

research or information on private 

sector incentive structures and 

partnership opportunities and barriers 

specific to public health preparedness 

and response. This study will evaluate 

the effectiveness of public-private 

partnership incentives from the 

perspective of private sector industries 

within the public health preparedness 

and response space. 

Study activities include the following: 

(1) Identification of public-private 

partnership incentives and target 

industries for public health 

preparedness and response; (2) 

interviews with industry leaders (in 

person or via telephone) to identify 

related public health emergency 

preparedness activities and partnership 

opportunities and barriers; (3) survey of 

private sector organization managers 

using on-line technology (Qualtrics) on 

key issues and attractiveness of 

partnership opportunities and 

incentives; and (4) framework 

development to identify partnership 

target organizations, opportunities, and 

incentives to promote public health 

emergency preparedness capabilities. 

CDC proposes to collect information 

from the private industry leaders in the 

public health preparedness and 

response space to accomplish this goal. 

The information collection project is 

composed of two parts: (1) Interviews 

and (2) an on-line general survey. The 

targeted interviews will seek 

respondents in the following eight 

sectors: Pharmaceutical/life sciences 

(n=8), health IT/mobile (n=8), retailers/ 

distributors (n=6), academia/research 

organization (n=6), hospital/healthcare 

provider (n=5), health insurance (n=4), 

logistics/transportation (n=4), and 

charitable organization/foundation 

(n=4). The interview questions and the 

information collected will vary 

significantly across the different sectors. 

The survey portion of the information 

collection consists of a larger survey 

administered to 200 individuals to reach 

a total sample population of 100 

(assuming a 50% response rate). CDC 

will conduct the interviews and 

administer the survey only one time to 

each individual respondent. CDC plans 

to conduct interviews and surveys 

within six months after OMB approval. 

Members of the research team will 

conduct the interviews. CDC will 

administer the surveys using the secure 

online software Qualtrics, and 

respondents will receive an email with 

a unique link that will direct them to 

the Qualtrics survey platform. The 

research team will then transfer data to 

CDC’s preferred Secure File Transfer 

Protocol (SFTP) client for secure storage 

and access. After this transfer, CDC will 

destroy all copies of the data that reside 

outside of the SFTP. Only the research 

team will have access to the interview 

transcripts and survey responses that 

will link responses to personally 

identifiable information. Researchers 

will use locked file cabinets to store 

securely, any printed or hand-written 

documents containing personal 

identifiable information. Once scanned 

or otherwise transferred into electronic 

files (which will also be transferred to 

the SFTP client), researchers will 

appropriately destroy the information. 

Only the research team will have 

access to the SFTP, which will require 

the user to enter a host address, 

username, password and port number. 

Any information removed from the 

SFTP client to be shared with outside 

parties will be presented in aggregated 

and de-identified form, unless otherwise 

compelled by law. CDC will retain and 

destroy all records in accordance with 

the applicable CDC Records Control 

Schedule. 

OPHPR is requesting an approval 

period of one year to collect this 

information. There is no cost to 

respondents other than the time to 

participate. The total estimated annual 

burden hours is 70 hours. A summary 

of annualized burden hours is below.